Kyphoplasty denied as experimental or investigational by Medicare?

Medicare's specific coverage criteria for kyphoplasty are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Medicare Denies Kyphoplasty as Experimental — and Why This Denial Is Challengeable

Kyphoplasty (balloon kyphoplasty) has been covered by Medicare for vertebral compression fractures for many years and is addressed in Medicare coverage policy. An "experimental" or "investigational" denial in this context is unusual and typically reflects one of the following: the specific clinical scenario falls outside the covered indication as defined by the applicable Medicare coverage determination; the claim was submitted under a code associated with a modified or newer technique that lacks separate coverage; or the denial was generated by a clinical reviewer who applied an incorrect standard. This denial type is worth challenging directly.

## Why This Denial Happens

Medicare covers kyphoplasty under specific clinical criteria set out in Local Coverage Determinations (LCDs) issued by the relevant Medicare Administrative Contractor (MAC). If the submitted claim does not meet the documented criteria — or if supporting documentation was not submitted — a reviewer may categorize the denial as experimental/investigational rather than as a medical-necessity denial. Additionally, variations in technique or equipment that differ from what the LCD describes can trigger this classification.

## Your Appeal Rights

Medicare's five-level appeal process applies:

1. Redetermination (MAC): within 120 days of the initial denial notice. 2. Reconsideration (QIC): within 180 days of the redetermination decision. 3. ALJ Hearing: when the amount in controversy meets the applicable threshold. 4. Medicare Appeals Council (DAB). 5. Federal District Court.

Expedited review (72-hour) is available when standard timing would seriously jeopardize health or ability to regain maximum function.

## Concrete Appeal Process

1. Identify the specific LCD or NCD under which kyphoplasty coverage applies for your MAC jurisdiction — these are publicly available on the CMS website. 2. Review the denial letter for the specific reason the reviewer classified the procedure as experimental. 3. Confirm that the procedure performed matches the covered procedure as described in the LCD (technique, device, indication). 4. File a redetermination with the MAC, attaching the LCD and documentation showing compliance.

## Documentation to Gather

• Operative report: detailing the technique used, the device, and the vertebral level(s) treated.
• Pre-procedure imaging: MRI, CT, or X-ray confirming the fracture and its characteristics consistent with coverage criteria in the applicable LCD.
• Diagnosis documentation: chart notes confirming the diagnosis, fracture acuity, and clinical indication.
• Treating physician statement: addressing the specific experimental/investigational classification and explaining why the procedure meets the covered criteria in the LCD.
• The applicable LCD: attach a copy and cite the relevant coverage criteria directly in the appeal.

## Criteria-Mapping Structure

Obtain the full text of the LCD for vertebral augmentation from the CMS LCD database. For each coverage criterion, provide the corresponding chart entry, imaging finding, or operative detail that satisfies it. Directly refute the experimental classification by showing that the procedure and indication are within the LCD's covered scope.